Product Information
MEMANTINE 5-10 MG TITRATION PK is a generic product labeled by Actavis Pharma, Inc., priced at $0.3724 per EA under NDC 00591390087. Its NADAC has been published 550 times since Dec 23, 2015.
FDA first approved this application on Oct 16, 2003.
Manufacturer
Actavis Pharma, Inc.NDC
00591390087
Classification
Generic
Dosage Form
KIT
Route
ORAL
Effective Date
10/22/2025
Approval Type
Authorized Generic (NDA)
FDA Application
NDA021487FDA Approved
10/16/2003
On Market Since
4/1/2015
Price Statistics
The NADAC for MEMANTINE 5-10 MG TITRATION PK has been published 550 times since Dec 23, 2015, and over the history we have for it it has declined 26.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3724 per EA |
|---|---|
| All-time high | $0.8779 (Sep 14, 2016) |
| All-time low | $0.2816 (Sep 18, 2024) |
| 52-week high | $0.3743 |
| 52-week low | $0.3724 |
| Median price | $0.3718 |
| Average price | $0.3900 |
| Largest weekly change | +72.4% (Apr 20, 2016) |
| Weeks tracked | 550 |
| Tracking since | Dec 23, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the memantine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
memantine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MEMANTINE 5-10 MG TITRATION PK?
The current National Average Drug Acquisition Cost (NADAC) for MEMANTINE 5-10 MG TITRATION PK, manufactured by Actavis Pharma, Inc., is $0.3724 per EA (NDC 00591390087), effective Sep 30, 2026.
How has the price of MEMANTINE 5-10 MG TITRATION PK changed over time?
Over the history we have for it, the NADAC for MEMANTINE 5-10 MG TITRATION PK has declined 26.5%. It has been tracked across 550 weekly CMS publications since Dec 23, 2015.
What are the highest and lowest recorded NADAC prices for MEMANTINE 5-10 MG TITRATION PK?
Since Dec 23, 2015, the NADAC for MEMANTINE 5-10 MG TITRATION PK has ranged from a low of $0.2816 (Sep 18, 2024) to a high of $0.8779 (Sep 14, 2016), with a median of $0.3718 per EA.
Are there cheaper alternatives to MEMANTINE 5-10 MG TITRATION PK?
No other NADAC-published product currently shares the active ingredient and strength of MEMANTINE 5-10 MG TITRATION PK in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MEMANTINE 5-10 MG TITRATION PK?
MEMANTINE 5-10 MG TITRATION PK (NDC 00591390087) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.